penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.
Company profile
Ticker
PEN
Exchange
Website
CEO
Adam Elsesser
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Penumbra Europe GmbH • Penumbra Neuro Australia Pty Ltd • Penumbra Neuro Canada Inc. • Penumbra Latin America Distribuidora de Equipamentos e Produtos Médicos Ltda. • Penumbra Interventional Therapies UK Ltd. • Penumbra Singapore Pte. Ltd. • Penumbra France SAS • Penumbra Israel Ltd • Penumbra Sweden AB • Penumbra Denmark ApS ...
PEN stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
24 Apr 24
DEFA14A
Additional proxy soliciting materials
24 Apr 24
DEF 14A
Definitive proxy
24 Apr 24
8-K
Changes in Registrant's Certifying Accountant
21 Mar 24
10-K
2023 FY
Annual report
22 Feb 24
8-K
Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
22 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
Penumbra, Inc. Reports Third Quarter 2023 Financial Results
2 Nov 23
8-K/A
Submission of Matters to a Vote of Security Holders
3 Aug 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
Transcripts
PEN
Earnings call transcript
2023 Q4
22 Feb 24
PEN
Earnings call transcript
2023 Q3
2 Nov 23
PEN
Earnings call transcript
2023 Q2
1 Aug 23
PEN
Earnings call transcript
2023 Q1
2 May 23
PEN
Earnings call transcript
2022 Q4
23 Feb 23
PEN
Earnings call transcript
2022 Q3
3 Nov 22
PEN
Earnings call transcript
2022 Q2
7 Aug 22
PEN
Earnings call transcript
2022 Q1
4 May 22
PEN
Earnings call transcript
2021 Q4
23 Feb 22
PEN
Earnings call transcript
2021 Q3
4 Nov 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 100.76 mm | 100.76 mm | 100.76 mm | 100.76 mm | 100.76 mm | 100.76 mm |
Cash burn (monthly) | 4.47 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 30.81 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 69.94 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 15.6 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
84.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 313 |
Opened positions | 37 |
Closed positions | 84 |
Increased positions | 103 |
Reduced positions | 122 |
13F shares | Current |
---|---|
Total value | 7.87 tn |
Total shares | 32.57 mm |
Total puts | 401.30 k |
Total calls | 758.50 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
FMR | 5.02 mm | $1.21 tn |
BLK Blackrock | 4.26 mm | $1.03 tn |
Vanguard | 3.60 mm | $870.86 bn |
Capital Research Global Investors | 2.68 mm | $647.74 bn |
T. Rowe Price | 1.96 mm | $478.26 bn |
STT State Street | 1.06 mm | $256.44 bn |
Clearbridge Advisors | 905.22 k | $218.98 bn |
Baillie Gifford & Co | 679.63 k | $164.41 bn |
RTW Investments | 673.37 k | $162.90 bn |
William Blair Investment Management | 656.96 k | $158.93 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 24 | Roberts Johanna | Common Stock | Payment of exercise | Dispose F | No | No | 210.19 | 193 | 40.57 k | 64,088 |
1 Apr 24 | Don W. Kassing | Common Stock | Sell | Dispose S | No | Yes | 223.18 | 170 | 37.94 k | 1,175 |
1 Apr 24 | Roberts Johanna | Common Stock | Sell | Dispose S | No | Yes | 223.71 | 1 | 223.71 | 64,281 |
1 Apr 24 | Roberts Johanna | Common Stock | Sell | Dispose S | No | Yes | 223.19 | 3 | 669.57 | 64,282 |
1 Apr 24 | Roberts Johanna | Common Stock | Sell | Dispose S | No | Yes | 221.77 | 1 | 221.77 | 64,285 |
1 Apr 24 | Roberts Johanna | Common Stock | Sell | Dispose S | No | Yes | 220.87 | 4 | 883.48 | 64,286 |
1 Apr 24 | Roberts Johanna | Common Stock | Sell | Dispose S | No | Yes | 219.84 | 5 | 1.10 k | 64,290 |
1 Apr 24 | Roberts Johanna | Common Stock | Sell | Dispose S | No | Yes | 219.14 | 24 | 5.26 k | 64,295 |
1 Apr 24 | Roberts Johanna | Common Stock | Sell | Dispose S | No | Yes | 217.78 | 109 | 23.74 k | 64,319 |
1 Apr 24 | Roberts Johanna | Common Stock | Sell | Dispose S | No | Yes | 217.02 | 233 | 50.57 k | 64,428 |
News
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
9 Apr 24
Piper Sandler Reiterates Overweight on Penumbra, Maintains $290 Price Target
3 Apr 24
Penumbra Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
22 Mar 24
Truist Securities Maintains Buy on Penumbra, Lowers Price Target to $280
22 Mar 24
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
23 Feb 24
Press releases
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
9 Apr 24
Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
22 Feb 24
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024
1 Feb 24